X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (300) 300
Journal Article (129) 129
Publication (8) 8
Conference Proceeding (2) 2
Newspaper Article (2) 2
Report (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (289) 289
basic electronic circuitry (280) 280
demodulation or transference of modulation from one carrier toanother (280) 280
electric communication technique (230) 230
transmission (206) 206
modulation (164) 164
transmission of digital information, e.g. telegraphiccommunication (125) 125
humans (82) 82
antennas, i.e. radio aerials (53) 53
basic electric elements (53) 53
male (40) 40
female (36) 36
index medicus (36) 36
infectious diseases (34) 34
adult (32) 32
middle aged (27) 27
australia (25) 25
medicine, general & internal (22) 22
aged (21) 21
microbiology (18) 18
physics (18) 18
australia - epidemiology (16) 16
queensland (15) 15
animals (12) 12
infection control (12) 12
research (12) 12
risk factors (12) 12
calculating (11) 11
computing (11) 11
counting (11) 11
retrospective studies (11) 11
adolescent (10) 10
anti-bacterial agents - therapeutic use (10) 10
electric digital data processing (10) 10
epidemiology (10) 10
health aspects (10) 10
human (10) 10
wireless communications networks (10) 10
analysis (9) 9
aged, 80 and over (8) 8
hospitals (8) 8
impedance networks, e.g. resonant circuits (8) 8
incidence (8) 8
infection (8) 8
infectious disease (8) 8
pulse technique (8) 8
resonators (8) 8
bacteremia (7) 7
drug utilization (7) 7
immunology (7) 7
infectious and parasitic diseases (7) 7
methicillin resistance (7) 7
mortality (7) 7
prospective studies (7) 7
staphylococcus aureus (7) 7
vancomycin (7) 7
cross infection (6) 6
infections (6) 6
nosocomial infections (6) 6
staphylococcal infections - microbiology (6) 6
time factors (6) 6
young adult (6) 6
anti-bacterial agents (5) 5
anti-bacterial agents - administration & dosage (5) 5
antibiotics (5) 5
antifungal agents - therapeutic use (5) 5
care and treatment (5) 5
child (5) 5
cross infection, epidemiology (5) 5
diagnosis (5) 5
drug utilization review (5) 5
intensive care units (5) 5
microbial sensitivity tests (5) 5
selecting (5) 5
telephonic communication (5) 5
treatment outcome (5) 5
usage (5) 5
biochemistry & molecular biology (4) 4
critical care medicine (4) 4
cross infection - epidemiology (4) 4
dosage and administration (4) 4
drug resistance, bacterial (4) 4
drug therapy (4) 4
fungemia - microbiology (4) 4
fungemia - mortality (4) 4
infection control - methods (4) 4
information storage (4) 4
information storage based on relative movement between recordcarrier and transducer (4) 4
management (4) 4
mass screening (4) 4
medicine (4) 4
patient outcomes (4) 4
performing operations (4) 4
population surveillance (4) 4
prevalence (4) 4
saccharomyces cerevisiae - genetics (4) 4
therapy (4) 4
transporting (4) 4
travel (4) 4
united-states (4) 4
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (411) 411
French (63) 63
German (44) 44
Swedish (6) 6
Finnish (4) 4
Norwegian (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Harris, Patrick N. A and Tambyah, Paul A and Lye, David C and Mo, Yin and Lee, Tau H and Yilmaz, Mesut and Alenazi, Thamer H and Arabi, Yaseen and Falcone, Marco and Bassetti, Matteo and Righi, Elda and Rogers, Benjamin A and Kanj, Souha and Bhally, Hasan and Iredell, Jon and Mendelson, Marc and Boyles, Tom H and Looke, David and Miyakis, Spiros and Walls, Genevieve and Al Khamis, Mohammed and Zikri, Ahmed and Crowe, Amy and Ingram, Paul and Daneman, Nick and Griffin, Paul and Athan, Eugene and Lorenc, Penelope and Baker, Peter and Roberts, Leah and Beatson, Scott A and Peleg, Anton Y and Harris-Brown, Tiffany and Paterson, David L and McNamara, J and Sieler, R and Garlick, J and Costa, J and Roney, J and Pratt, N and Tabaja, H and Kmeid, J and Tayyar, R and El Zein, S and Jones, S and Cowan, R and Tai, A and Lin, B and Rad, B and MacMorran, E and Pollard, J and Dinleyici, R and Istanbullu, A and Ceylan, B and Mert, A and Hashhoush, M and Dalwi, T and Korman, T and Azzam, R and Birrell, M and Hughes, C and Khan, S and Lau, J and Lee, L and Lim, K and Lin, Y.D and Lister, D and New, D and Rafiei, N and Stewart, J and Tai, A and Trad, M.A and Aye Yeung, V and McBride, S and Holland, D and Hopkins, C and Luey, C and Taylor, S and Morpeth, S and Finney, M and Martin, M and Holland, U and Ali, J and Jureen, R and Underwood, N and Henderson, A and Runnegar, N and Slavin, M and Robinson, O and Rishu, A and Shawkat, S and Fish, J and Chin Liew, K and Newton, P and Merelli, M and Carnelutti, A and Ussai, S and Pecori, D and Izharuddin, E and Young, B and ...
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
Journal Article
Journal Article
by Chen, Sharon and Slavin, Monica and Nguyen, Quoc and Marriott, Deborah and Playford, E. Geoffrey and Ellis, David and Sorrell, Tania and McBride, J and Coulter, C and McCormack, J and Walmsley, K and Looke, D and Johnson, B and Nimmo, G and Drummond, D and Forgan-Smith, R and Preston, E and Allworth, A and Faoagali, J and Gerns, N and Botes, J and Cherian, S and Robson, J and Vohra, R and Norton, R and O'Kane, G and Robb, D and Gottlieb, T and Chambers, I and DeWit, D and Carroll, M and Dobson, P and Ferguson, J and Graves, S and Tierney, L and Jozwiak, F and Munro, R and Tomasotos, V and Pickles, R and Holland, J and Groenwald, F and Hale, K and Watson, M and Vaz, R and Hardiman, R and Baleriola, C and Ryan, S and Pritchard, R and Weeks, K and Benn, R and Adams, N and Lawrence, R and Taylor, P and Lindstrom, S and Harkness, J and Palasanthrian, P and Grant, R and McPetrie, R and Johnson, R and Halliday, C and Maszewska, K and Lee, O.C and Meyer, W and Dennis, N and Newton, P and Franklin, C and Morrisey, O and Spelman, D and Wesselingh, S and Speed, B and Hellsten, J and Mayall, B and Russell, J and Broughton, S and Woolley, I and Coloe, S and Sherman, A and Korman, T and Graves, S and Huysmans, M and Sherman, A and Gordon, D and Rowlands, K and Shaw, D and Ferguson, W and Ritchie, B and Handke, R and Beaman, M and Chiam, A and McCarthy, J and Heath, C and Altmann, S and Arthur, I and Speers, D and Cox, E and Cooley, L and McGregor, A and Currie, B and Lum, G and Fisher, D and Australian Candidemia Sty and Australian Candidemia Study and the Australian Candidemia Study
Emerging Infectious Diseases, ISSN 1080-6040, 2006, Volume 12, Issue 10, pp. 1508 - 1516
Journal Article
Critical Care, ISSN 1364-8535, 07/2009, Volume 13, Issue 4, pp. R115 - R115
Journal Article
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Original Investigation | Research
Journal Article
Journal Article
Journal Article